Adrian works to develop, characterize, and optimize Life Edit Therapeutics’ novel genome editing enzymes as part of the Technology Development team.
Adrian obtained his PhD in Genetics with a Bioinformatics concentration at the University of Rochester (NY), where he studied and characterized different CRISPR-Cas13 enzymes and developed new design strategies for efficient and specific RNA-targeting applications using Cas13.
.svg)
.svg)
To rewrite the future by curing disease, making any edit, anywhere.
To pave the way to faster, safer, gene editing therapeutics that cure disease and improve patient lives.
We’re guided by curiosity, rigor, and integrity. We believe in discovery and unlimited potential. We care about science and the lives of patients.
